Somatostatin Receptor Positive Tumours clinical trials

Explore recruiting somatostatin receptor positive tumours clinical trials.

Recruiting somatostatin receptor positive tumours studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Somatostatin Receptor Positive Tumours trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Phase I trial with 177Lu-DOTA-TATE and olaparib in somatostatin receptor positive tumours

Sweden

Human Pharmacology (Phase I)- Other EU CTIS Study details

Somatostatin Receptor Positive Tumours trials by city

Somatostatin Receptor Positive Tumours in Toronto Somatostatin Receptor Positive Tumours in Vancouver Somatostatin Receptor Positive Tumours in Montreal Somatostatin Receptor Positive Tumours in Calgary Somatostatin Receptor Positive Tumours in Edmonton Somatostatin Receptor Positive Tumours in Ottawa Somatostatin Receptor Positive Tumours in Winnipeg Somatostatin Receptor Positive Tumours in Quebec City Somatostatin Receptor Positive Tumours in Hamilton Somatostatin Receptor Positive Tumours in Kitchener Somatostatin Receptor Positive Tumours in London Somatostatin Receptor Positive Tumours in Halifax Somatostatin Receptor Positive Tumours in New York Somatostatin Receptor Positive Tumours in Los Angeles Somatostatin Receptor Positive Tumours in Chicago Somatostatin Receptor Positive Tumours in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease